AnaptysBio, Inc.
ANAB
$26.58
$0.240.91%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -42.21M | -37.31M | -39.85M | -44.26M | -26.41M |
| Total Depreciation and Amortization | 604.00K | 592.00K | 587.00K | 593.00K | 606.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.92M | 9.25M | 10.60M | 11.01M | 9.21M |
| Change in Net Operating Assets | -2.66M | -9.00M | 3.25M | 8.09M | 5.91M |
| Cash from Operations | -34.35M | -36.47M | -25.41M | -24.57M | -10.69M |
| Capital Expenditure | -280.00K | -162.00K | -190.00K | -175.00K | -175.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 49.46M | 30.80M | -20.27M | 85.57M | 21.67M |
| Cash from Investing | 49.18M | 30.64M | -20.46M | 85.40M | 21.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 264.00K | 160.00K | 783.00K | 1.27M | 3.42M |
| Repurchase of Common Stock | 0.00 | 0.00 | -12.47M | -37.53M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.42M | -3.23M | -1.80M | -1.31M | -1.47M |
| Cash from Financing | -5.16M | -3.07M | -13.49M | -37.57M | 1.95M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.67M | -8.91M | -59.36M | 23.25M | 12.76M |
